70
October 31, 2025 — Leads & Copy — Immunome, Inc. (Nasdaq: IMNM) will present at the 2nd Annual Guggenheim Healthcare Innovation Conference on Tuesday, Nov. 11, 2025, at 8:30 a.m. ET.
Interested parties can access the live audio webcast for this conference from the Investor Relations section of Immunome’s website. The webcast replay will be available after the live presentation for about 30 days.
Immunome is a clinical-stage targeted oncology company that develops first-in-class and best-in-class targeted therapies to improve outcomes for cancer patients. The company’s pipeline programs include varegacestat (formerly AL102), IM-1021, and IM-3050, as well as preclinical ADCs IM-1617, IM-1335, and IM-1340.
Source: Immunome, Inc.
